Delivery Systems
23
0
0
22
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
39%
9 trials in Phase 3/4
14%
3 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (23)
Determining the Viability a Lozenge Dosage for Probiotics
Comparison of 2 NovoFine® Needles on the Reflux of Insulin
Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics
Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations
Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle
Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes
Comparison of NovoFine® Needles (4 mm vs. 6 mm)
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin
Evaluating the Use of Two Different Needles in Subjects With Diabetes
Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe
Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes
Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus
Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™
Evaluation of Safety and Parameters of Application Technique
Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™
Novofine Autocover Safety Needle Versus BD Safety Glide
A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump